Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52


Cytotoxic anti-circumsporozoite antibodies target malaria sporozoites in the host skin.

Aliprandini E, Tavares J, Panatieri RH, Thiberge S, Yamamoto MM, Silvie O, Ishino T, Yuda M, Dartevelle S, Traincard F, Boscardin SB, Amino R.

Nat Microbiol. 2018 Nov;3(11):1224-1233. doi: 10.1038/s41564-018-0254-z. Epub 2018 Oct 22.


Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB.

Bruening J, Lasswitz L, Banse P, Kahl S, Marinach C, Vondran FW, Kaderali L, Silvie O, Pietschmann T, Meissner F, Gerold G.

PLoS Pathog. 2018 Jul 19;14(7):e1007111. doi: 10.1371/journal.ppat.1007111. eCollection 2018 Jul.


Plasmodium sporozoites can invade hepatocytic cells independently of the Ephrin receptor A2.

Langlois AC, Marinach C, Manzoni G, Silvie O.

PLoS One. 2018 Jul 5;13(7):e0200032. doi: 10.1371/journal.pone.0200032. eCollection 2018.


Differential activity of methylene blue against erythrocytic and hepatic stages of Plasmodium.

Bosson-Vanga H, Franetich JF, Soulard V, Sossau D, Tefit M, Kane B, Vaillant JC, Borrmann S, Müller O, Dereuddre-Bosquet N, Le Grand R, Silvie O, Mazier D.

Malar J. 2018 Apr 3;17(1):143. doi: 10.1186/s12936-018-2300-y.


A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection.

Zanghì G, Vembar SS, Baumgarten S, Ding S, Guizetti J, Bryant JM, Mattei D, Jensen ATR, Rénia L, Goh YS, Sauerwein R, Hermsen CC, Franetich JF, Bordessoulles M, Silvie O, Soulard V, Scatton O, Chen P, Mecheri S, Mazier D, Scherf A.

Cell Rep. 2018 Mar 13;22(11):2951-2963. doi: 10.1016/j.celrep.2018.02.075.


Tissue-specific cellular immune responses to malaria pre-erythrocytic stages.

Silvie O, Amino R, Hafalla JC.

Curr Opin Microbiol. 2017 Dec;40:160-167. doi: 10.1016/j.mib.2017.12.001. Epub 2017 Dec 5. Review.


Profiling MHC II immunopeptidome of blood-stage malaria reveals that cDC1 control the functionality of parasite-specific CD4 T cells.

Draheim M, Wlodarczyk MF, Crozat K, Saliou JM, Alayi TD, Tomavo S, Hassan A, Salvioni A, Demarta-Gatsi C, Sidney J, Sette A, Dalod M, Berry A, Silvie O, Blanchard N.

EMBO Mol Med. 2017 Nov;9(11):1605-1621. doi: 10.15252/emmm.201708123.


Plasmodium P36 determines host cell receptor usage during sporozoite invasion.

Manzoni G, Marinach C, Topçu S, Briquet S, Grand M, Tolle M, Gransagne M, Lescar J, Andolina C, Franetich JF, Zeisel MB, Huby T, Rubinstein E, Snounou G, Mazier D, Nosten F, Baumert TF, Silvie O.

Elife. 2017 May 16;6. pii: e25903. doi: 10.7554/eLife.25903.


Sequestration of cholesterol within the host late endocytic pathway restricts liver-stage Plasmodium development.

Petersen W, Stenzel W, Silvie O, Blanz J, Saftig P, Matuschewski K, Ingmundson A.

Mol Biol Cell. 2017 Mar 15;28(6):726-735. doi: 10.1091/mbc.E16-07-0531. Epub 2017 Jan 25.


Malaria Sporozoites Traverse Host Cells within Transient Vacuoles.

Risco-Castillo V, Topçu S, Marinach C, Manzoni G, Bigorgne AE, Briquet S, Baudin X, Lebrun M, Dubremetz JF, Silvie O.

Cell Host Microbe. 2015 Nov 11;18(5):593-603.


CD81 is required for rhoptry discharge during host cell invasion by Plasmodium yoelii sporozoites.

Risco-Castillo V, Topçu S, Son O, Briquet S, Manzoni G, Silvie O.

Cell Microbiol. 2014 Oct;16(10):1533-48. doi: 10.1111/cmi.12309. Epub 2014 Jun 2.


A rapid and robust selection procedure for generating drug-selectable marker-free recombinant malaria parasites.

Manzoni G, Briquet S, Risco-Castillo V, Gaultier C, Topçu S, Ivănescu ML, Franetich JF, Hoareau-Coudert B, Mazier D, Silvie O.

Sci Rep. 2014 Apr 23;4:4760. doi: 10.1038/srep04760.


The Plasmodium protein P113 supports efficient sporozoite to liver stage conversion in vivo.

Offeddu V, Rauch M, Silvie O, Matuschewski K.

Mol Biochem Parasitol. 2014 Feb;193(2):101-9. doi: 10.1016/j.molbiopara.2014.03.002. Epub 2014 Mar 20.


Post-transcriptional silencing of UIS4 in Plasmodium berghei sporozoites is important for host switch.

Silvie O, Briquet S, Müller K, Manzoni G, Matuschewski K.

Mol Microbiol. 2014 Mar;91(6):1200-13. doi: 10.1111/mmi.12528. Epub 2014 Feb 17.


The spatiotemporal dynamics and membranous features of the Plasmodium liver stage tubovesicular network.

Grützke J, Rindte K, Goosmann C, Silvie O, Rauch C, Heuer D, Lehmann MJ, Mueller AK, Brinkmann V, Matuschewski K, Ingmundson A.

Traffic. 2014 Apr;15(4):362-82. doi: 10.1111/tra.12151. Epub 2014 Feb 13.


Unique apicomplexan IMC sub-compartment proteins are early markers for apical polarity in the malaria parasite.

Poulin B, Patzewitz EM, Brady D, Silvie O, Wright MH, Ferguson DJ, Wall RJ, Whipple S, Guttery DS, Tate EW, Wickstead B, Holder AA, Tewari R.

Biol Open. 2013 Sep 16;2(11):1160-70. doi: 10.1242/bio.20136163. eCollection 2013.


[Plasmodium sporozoite entry pathways during malaria liver infection].

Risco-Castillo V, Son O, Franetich JF, Rubinstein E, Mazier D, Silvie O.

Biol Aujourdhui. 2013;207(4):219-29. doi: 10.1051/jbio/2013021. Epub 2014 Mar 5. French.


The Puf-family RNA-binding protein Puf2 controls sporozoite conversion to liver stages in the malaria parasite.

Müller K, Matuschewski K, Silvie O.

PLoS One. 2011;6(5):e19860. doi: 10.1371/journal.pone.0019860. Epub 2011 May 18.


Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery.

Dembele L, Gego A, Zeeman AM, Franetich JF, Silvie O, Rametti A, Le Grand R, Dereuddre-Bosquet N, Sauerwein R, van Gemert GJ, Vaillant JC, Thomas AW, Snounou G, Kocken CH, Mazier D.

PLoS One. 2011 Mar 31;6(3):e18162. doi: 10.1371/journal.pone.0018162.


Cell biology and immunology of malaria.

Hafalla JC, Silvie O, Matuschewski K.

Immunol Rev. 2011 Mar;240(1):297-316. doi: 10.1111/j.1600-065X.2010.00988.x. Review.


Natural immunization against malaria: causal prophylaxis with antibiotics.

Friesen J, Silvie O, Putrianti ED, Hafalla JC, Matuschewski K, Borrmann S.

Sci Transl Med. 2010 Jul 14;2(40):40ra49. doi: 10.1126/scitranslmed.3001058.


The Plasmodium serine-type SERA proteases display distinct expression patterns and non-essential in vivo roles during life cycle progression of the malaria parasite.

Putrianti ED, Schmidt-Christensen A, Arnold I, Heussler VT, Matuschewski K, Silvie O.

Cell Microbiol. 2010 Jun;12(6):725-39. doi: 10.1111/j.1462-5822.2009.01419.x. Epub 2009 Dec 21.


The Ig domain protein CD9P-1 down-regulates CD81 ability to support Plasmodium yoelii infection.

Charrin S, Yalaoui S, Bartosch B, Cocquerel L, Franetich JF, Boucheix C, Mazier D, Rubinstein E, Silvie O.

J Biol Chem. 2009 Nov 13;284(46):31572-8. doi: 10.1074/jbc.M109.057927. Epub 2009 Sep 17.


Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites.

Putrianti ED, Silvie O, Kordes M, Borrmann S, Matuschewski K.

J Infect Dis. 2009 Mar 15;199(6):899-903.


Lateral organization of membrane proteins: tetraspanins spin their web.

Charrin S, le Naour F, Silvie O, Milhiet PE, Boucheix C, Rubinstein E.

Biochem J. 2009 May 13;420(2):133-54. doi: 10.1042/BJ20082422. Review.


Disruption of Plasmodium sporozoite transmission by depletion of sporozoite invasion-associated protein 1.

Engelmann S, Silvie O, Matuschewski K.

Eukaryot Cell. 2009 Apr;8(4):640-8. doi: 10.1128/EC.00347-08. Epub 2009 Jan 30.


The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity.

Bongfen SE, Ntsama PM, Offner S, Smith T, Felger I, Tanner M, Alonso P, Nebie I, Romero JF, Silvie O, Torgler R, Corradin G.

Vaccine. 2009 Jan 7;27(2):328-35. doi: 10.1016/j.vaccine.2008.09.097. Epub 2008 Nov 5.


Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes.

van Schaijk BC, Janse CJ, van Gemert GJ, van Dijk MR, Gego A, Franetich JF, van de Vegte-Bolmer M, Yalaoui S, Silvie O, Hoffman SL, Waters AP, Mazier D, Sauerwein RW, Khan SM.

PLoS One. 2008;3(10):e3549. doi: 10.1371/journal.pone.0003549. Epub 2008 Oct 28.


Temperature shift and host cell contact up-regulate sporozoite expression of Plasmodium falciparum genes involved in hepatocyte infection.

Siau A, Silvie O, Franetich JF, Yalaoui S, Marinach C, Hannoun L, van Gemert GJ, Luty AJ, Bischoff E, David PH, Snounou G, Vaquero C, Froissard P, Mazier D.

PLoS Pathog. 2008 Aug 8;4(8):e1000121. doi: 10.1371/journal.ppat.1000121.


Interactions of the malaria parasite and its mammalian host.

Silvie O, Mota MM, Matuschewski K, Prudêncio M.

Curr Opin Microbiol. 2008 Aug;11(4):352-9. doi: 10.1016/j.mib.2008.06.005. Review.


A sporozoite asparagine-rich protein controls initiation of Plasmodium liver stage development.

Silvie O, Goetz K, Matuschewski K.

PLoS Pathog. 2008 Jun 13;4(6):e1000086. doi: 10.1371/journal.ppat.1000086.


Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain.

Yalaoui S, Zougbédé S, Charrin S, Silvie O, Arduise C, Farhati K, Boucheix C, Mazier D, Rubinstein E, Froissard P.

PLoS Pathog. 2008 Feb 29;4(2):e1000010. doi: 10.1371/journal.ppat.1000010.


A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial.

Okitsu SL, Silvie O, Westerfeld N, Curcic M, Kammer AR, Mueller MS, Sauerwein RW, Robinson JA, Genton B, Mazier D, Zurbriggen R, Pluschke G.

PLoS One. 2007 Dec 5;2(12):e1278.


Structure-activity-based design of a synthetic malaria peptide eliciting sporozoite inhibitory antibodies in a virosomal formulation.

Okitsu SL, Kienzl U, Moehle K, Silvie O, Peduzzi E, Mueller MS, Sauerwein RW, Matile H, Zurbriggen R, Mazier D, Robinson JA, Pluschke G.

Chem Biol. 2007 May;14(5):577-87.


Alternative invasion pathways for Plasmodium berghei sporozoites.

Silvie O, Franetich JF, Boucheix C, Rubinstein E, Mazier D.

Int J Parasitol. 2007 Feb;37(2):173-82. Epub 2006 Oct 30.


Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species.

Silvie O, Greco C, Franetich JF, Dubart-Kupperschmitt A, Hannoun L, van Gemert GJ, Sauerwein RW, Levy S, Boucheix C, Rubinstein E, Mazier D.

Cell Microbiol. 2006 Jul;8(7):1134-46.


Cholesterol contributes to the organization of tetraspanin-enriched microdomains and to CD81-dependent infection by malaria sporozoites.

Silvie O, Charrin S, Billard M, Franetich JF, Clark KL, van Gemert GJ, Sauerwein RW, Dautry F, Boucheix C, Mazier D, Rubinstein E.

J Cell Sci. 2006 May 15;119(Pt 10):1992-2002.


New approach for high-throughput screening of drug activity on Plasmodium liver stages.

Gego A, Silvie O, Franetich JF, Farhati K, Hannoun L, Luty AJ, Sauerwein RW, Boucheix C, Rubinstein E, Mazier D.

Antimicrob Agents Chemother. 2006 Apr;50(4):1586-9.


Do apoptotic Plasmodium-infected hepatocytes initiate protective immune responses?

Renia L, Maranon C, Hosmalin A, Gruner AC, Silvie O, Snounou G.

J Infect Dis. 2006 Jan 1;193(1):163-4; author reply 164-5. No abstract available.


Laser capture microdissection of hepatic stages of the human parasite Plasmodium falciparum for molecular analysis.

Semblat JP, Silvie O, Franetich JF, Mazier D.

Methods Mol Biol. 2005;293:301-7. Review.


Malaria sporozoite: migrating for a living.

Silvie O, Franetich JF, Rénia L, Mazier D.

Trends Mol Med. 2004 Mar;10(3):97-100; discussion 100-1. Review.


A tiny thread towards a tetraspanin function.

Boucheix C, Silvie O, Rubinstein E, Mazier D.

Pathol Biol (Paris). 2004 Mar;52(2):55-7. No abstract available.


Transcription status of vaccine candidate genes of Plasmodium falciparum during the hepatic phase of its life cycle.

Bodescot M, Silvie O, Siau A, Refour P, Pino P, Franetich JF, Hannoun L, Sauerwein R, Mazier D.

Parasitol Res. 2004 Apr;92(6):449-52. Epub 2004 Feb 12.


A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites.

Silvie O, Franetich JF, Charrin S, Mueller MS, Siau A, Bodescot M, Rubinstein E, Hannoun L, Charoenvit Y, Kocken CH, Thomas AW, Van Gemert GJ, Sauerwein RW, Blackman MJ, Anders RF, Pluschke G, Mazier D.

J Biol Chem. 2004 Mar 5;279(10):9490-6. Epub 2003 Dec 15.


The N'-terminal domain of glyceraldehyde-3-phosphate dehydrogenase of the apicomplexan Plasmodium falciparum mediates GTPase Rab2-dependent recruitment to membranes.

Daubenberger CA, Tisdale EJ, Curcic M, Diaz D, Silvie O, Mazier D, Eling W, Bohrmann B, Matile H, Pluschke G.

Biol Chem. 2003 Aug;384(8):1227-37.


In vitro activities of 25 quinolones and fluoroquinolones against liver and blood stage Plasmodium spp.

Mahmoudi N, Ciceron L, Franetich JF, Farhati K, Silvie O, Eling W, Sauerwein R, Danis M, Mazier D, Derouin F.

Antimicrob Agents Chemother. 2003 Aug;47(8):2636-9.


[CD81: a tetraspanin implicated in Plasmodium infection].

Silvie O, Rubinstein E, Boucheix C, Mazier D.

Med Sci (Paris). 2003 Feb;19(2):169-71. French. No abstract available.


Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.

Silvie O, Rubinstein E, Franetich JF, Prenant M, Belnoue E, Rénia L, Hannoun L, Eling W, Levy S, Boucheix C, Mazier D.

Nat Med. 2003 Jan;9(1):93-6. Epub 2002 Dec 16.


Diagnosis of malaria using thick bloodsmears: definition and evaluation of a faster protocol with improved readability.

Thellier M, Datry A, Alfa Cissé O, San C, Biligui S, Silvie O, Danis M.

Ann Trop Med Parasitol. 2002 Mar;96(2):115-24.


Laser capture microdissection of Plasmodium falciparum liver stages for mRNA analysis.

Semblat JP, Silvie O, Franetich JF, Hannoun L, Eling W, Mazier D.

Mol Biochem Parasitol. 2002 May;121(2):179-83.


Supplemental Content

Loading ...
Support Center